Ubs Oconnor LLC Elanco Animal Health Inc Transaction History

Ubs Oconnor LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$8.08 - $10.37 $437,742 - $561,805	54,176 New	54,176 $545 Million
Q1 2023 May 15, 2023	BUY	$8.79 - $14.58 $17,580 - $29,160	2,000 Added 5.0%	42,000 $394,000
Q4 2022 Feb 14, 2023	BUY	$11.49 - $13.65 $459,600 - $546,000	40,000 New	40,000 $0
Q4 2020 Feb 17, 2021	SELL	$27.53 - $33.79 $3.17 Million - $3.89 Million	-115,000 Reduced 76.67%	35,000 $1.07 Million
Q4 2019 Feb 14, 2020	SELL	$25.29 - $29.45 $8.09 Million - $9.42 Million	-320,000 Reduced 68.09%	150,000 $4.42 Million
Q3 2019 Nov 14, 2019	BUY	$25.62 - $34.96 $12 Million - $16.4 Million	470,000 New	470,000 $12.5 Million

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.71B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.